The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Honors Accomplishments in Rheumatology

ACR Honors Accomplishments in Rheumatology

December 1, 2010 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A: This is positively far and away the most prestigious award I’ve ever received. It’s a very humbling experience. I’m completely blown away.

You Might Also Like
  • The ACR Honors Contributions to Rheumatology
  • ACR Honors Contributions to Rheumatology
  • The ACR/ARHP Honors Members for Contributions to Rheumatology
Explore This Issue
December 2010
Also By This Author
  • Sjögren’s Awareness Month: Educate Patients, Families, Caregivers

 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Mariana J. Kaplan, MD

ACR Award

Henry Kunkel Young Investigator

Mariana J. Kaplan, MD
Associate Professor of Internal Medicine, Division of Rheumatology, University of Michigan Medical School, Ann Arbor

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Background: A 15-year ACR member, Dr. Kaplan’s research focuses on the identification of mechanisms that lead to organ damage in systemic autoimmune diseases. She has proposed a new paradigm for the pathogenesis, as well as a potential treatment, of premature atherosclerosis that complicates autoimmune diseases, particularly lupus. Dr. Kaplan proposes that there is a profound imbalance between vascular damage and vascular repair in lupus, with a critical role for Type 1 interferons. The enhanced vascular damage and impaired repair induced by these interferons may also be implicated in the progression of kidney disease in lupus through a vaculopathic effect. She also is identifying the role of anomalies in antigen-presenting cells in lupus pathogenesis, particularly neutrophils and dendritic cells.

Dr. Kaplan is a member of the ACR/REF Scientific Advisory Council and the Lupus Foundation of America. She is section editor of the Journal of Immunology, as well as advisory editor for Arthritis & Rheumatism. She has been elected to the American Society of Clinical Investigation.

Q: What should rheumatologists in clinical practice know about your research?

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

A: We are trying to identify potential targets that are implicated in the development of chronic complications in patients with lupus and other autoimmune diseases. As patients live longer, they accrue significantly more damage and the blood vessels are an important target.

Identifying Type 1 interferons as crucial culprits in the development of premature vascular damage could lead to significant changes in prevention strategies. Now that clinical trials that block Type 1 interferon effects in lupus and other diseases are ongoing, identifying these molecules as potentially very important in damage of the blood vessels may lead to changes in the paradigm of how we treat these diseases and prevent their complications.

Q: What specifically attracted you to lupus research?

A: It’s a disease that affects mostly young women and significantly impacts their quality of life; the multisystemic nature of the disease; the lack of understanding of what leads to the loss of self-tolerance. And then that there is so little known and so much to learn about these diseases. There is a high potential for significant improvement of their quality of life, if we better understand how autoimmunity starts, evolves, and perpetuates.

Pages: 1 2 3 4 5 6 7 8 9 10 11 | Single Page

Filed Under: Awards, Career Development, Professional Topics, Profiles Tagged With: AC&R, Award, Career, Patients, Research, TrainingIssue: December 2010

You Might Also Like:
  • The ACR Honors Contributions to Rheumatology
  • ACR Honors Contributions to Rheumatology
  • The ACR/ARHP Honors Members for Contributions to Rheumatology
  • Arthritis Foundation Honors Excellence in Rheumatology

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.